Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Investigation of three flavonoids as potent tau aggregation inhibitors and In vivo demonstration of myricetin

Pharmacological Research - Natural Products(2025)10.1016/j.prenap.2025.100449Source: DataRank Database

Investigation of three flavonoids as potent tau aggregation inhibitors and In vivo demonstration of myricetin is a research paper published in Pharmacological Research - Natural Products (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: greenTopics (15)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Trae Hillyer,Bovinari A. Csubak ORCID,Noah Aguirre ORCID,Samuel D. Crish ORCID,Chounghun Kang ORCID

Live enrichment

PubMed:41531988 OpenAlex:https://openalex.org/W4417079810

National Institutes of Health

Grant: 1R03NS135326

National Institutes of Health

Grant: 1R01AG076699

NINDS NIH HHS

Grant: R03 NS135326

NIA NIH HHS

Grant: R01 AG076699

FWCI

0.00

Citation Percentile

0.4%

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12795586/

publisherhttps://api.elsevier.com/content/article/PII:S295019972500309X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S295019972500309X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.prenap.2025.100449

Fields of Study

Alzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesChemical synthesis and alkaloids

Keywords

TauopathyIn vivoMyricetinAmyloid βAlzheimer's diseasePharmacokineticsIn vitroNeuroprotectionFlavonoidsTauTau DisassemblerTau Inhibitor